Stock Ratings / Health Care / QTI / financials

ITOC (35) POCI (34) ECOR (38) OM (35) ⌘ Pro Terminal →

QT Imaging Holdings Inc. (QTI) Revenue-to-Profit Sankey Flow & SEC XBRL Financials

Q: How profitable is QT Imaging Holdings Inc. (QTI)?

In FY 2025 (10-K), QTI converted $18.9M of revenue into a 45.4% gross margin, 0% operating margin, and $0 in free cash flow (0% FCF margin).

$2.21 -3.07% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

QT Imaging Holdings Inc. (QTI) carries a Roarable Rating of D- (Sell) with 38/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $32.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for QTI)Realized 20D OHLCV Swing Band: ±12.5%

VISUAL REVENUE-TO-PROFIT SANKEY WATERFALL • FY 2025 (10-K)

How QTI Turns Every Dollar of Sales Into Real Bottom-Line Profit

Free Cash Flow:$0 (0% FCF Margin)

Multi-Year SEC EDGAR XBRL Revenue, Net Profit & Free Cash Flow Trajectory

■ Revenue■ Net Profit■ Free Cash Flow

FY23

Rev $40.4K

FY24

Rev $4.9M

FY25

Rev $18.9M

Fiscal Year	Revenue	Gross Margin	Op Margin	Net Profit	Free Cash Flow	ROIC %
FY 2025	$18.9M	45.4%	-23.4%	-$21.1M	-$9.1M	-45%
FY 2024	$4.9M	54.1%	-80%	-$9.0M	-$10.1M	-45%
FY 2023	$40.4K	45.4%	-80%	-$6.1M	-$2.7M	-35%

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring QTI)

✓Walkthrough of QTI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

QTI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -66.36%🛡️ HOLDING TREND SUPPORT

2026-10-30O $2.20H $2.21L $2.14C $2.21VOL 22.7K

RES: $2.86SUP: $2.18SMA50: $2.60SMA200: $4.48

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

QTI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 QTI Butterfly Map → + Track QTI →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +180.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on QTI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for QTI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for QTI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (QTI)

Health Care Rank #725 of 1016 ⚔️ ITOC vs QTI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (QTI vs. ITOC, POCI, ECOR, OM)

Industry: Biotechnology: Electromedical & Electrotherapeutic Apparatus (26 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, QT Imaging Holdings Inc. (QTI) ranks #725 by composite RQD confidence (38/100, grade D-) and #796 by equity capitalization ($32.3M). Within this direct 5-issuer industry benchmark cohort, QTI leads on earnings valuation at N/A trailing P/E, while OM leads on capital efficiency and profitability with -28.0% ROIC and 39.1% gross margin. QTI currently leads its immediate peer cohort in composite quantitative strength at 38/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
QTI ACTIVE QT Imaging Holdings Inc.	D-	38/100	—	45.4%	-35.0%	-3.07%	$32.3M	Benchmark Subject
ITOC iTonic Holdings Ltd (Class A)	D-	35/100	—	62.6%	-35.0%	-4.99%	$20.9M	/itoc-vs-qti →
POCI Precision Optics Corporation Inc.	E	34/100	—	17.8%	-35.0%	+5.76%	$50.5M	/poci-vs-qti →
ECOR electroCore Inc.	D-	38/100	—	86.8%	-35.0%	-3.68%	$73.1M	/ecor-vs-qti →
OM Outset Medical Inc.	D-	35/100	—	39.1%	-28.0%	-3.46%	$78.8M	/om-vs-qti →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001844505

In its most recent audited fiscal period (FY2025, filed 2025-12-31), QT Imaging Holdings Inc. (QTI) reported GAAP revenue of $18.9M (+287.9% vs. FY2024 revenue of $4.9M , and +46796.3% cumulative change since FY2023) , GAAP net income of -$21.1M, operating cash flow of -$9.0M, and free cash flow of -$9.1M (+10.3% YoY). On the balance sheet, QTI closed FY2025 with $23.0M in total assets against $0 in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$18.9M	-$21.1M	-$9.0M	-$9.1M	$23.0M	—
FY2024 (FY)	2024-12-31	$4.9M	-$9.0M	-$10.0M	-$10.1M	$6.1M	—
FY2023 (FY)	2023-12-31	$40.4K	-$6.1M	-$2.7M	-$2.7M	—	—

3. QTI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is QTI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, QT Imaging Holdings Inc. (NASDAQ: QTI) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 38/100 at a spot price of $2.21 (-3.07% 1D, market cap $32.3M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 13/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, QTI ranks #725 in composite RQD confidence.

How does QTI compare to ITOC and POCI in the Health Care sector?

Within the Health Care sector (Biotechnology: Electromedical & Electrotherapeutic Apparatus), QTI carries a Roarable D- (38/100 RQD), trailing P/E of N/A, gross margin of 45.4%, and ROIC of -35.0%. By comparison, ITOC (iTonic Holdings Ltd (Class A)) holds a D- grade (35/100 RQD, P/E N/A, ROIC -35.0%, cap $20.9M) and POCI (Precision Optics Corporation Inc.) posts a E grade (34/100 RQD, P/E N/A, ROIC -35.0%, cap $50.5M). Among the 5-stock peer group, QTI leads on earnings multiple (N/A) while OM leads on capital efficiency (-28.0% ROIC).

What are the biggest fundamental strengths and SEC risk factors for QTI?

Per QTI's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001844505), QT Imaging Holdings Inc. generated $18.9M in revenue (+287.9% YoY), -$21.1M in net income, and -$9.1M in free cash flow against $23.0M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is QTI trading relative to its 50-day, 200-day, and 52-week technical levels?

QTI last traded at $2.21 (-3.07% on volume of 26,798 shares), positioning the stock -15.00% below its 50-day simple moving average ($2.60) and -50.67% below its 200-day simple moving average ($4.48). Across its 52-week range of $2.14 to $7.60, QTI sits at the 1.3% percentile with a 14-day RSI of 30.7 (OVERSOLD (<32)) and an implied next-earnings move of ±12.5% ($1.93 to $2.49).